Mid Day Increased Volume: TRMB, NOAH, STM, FTEK, RAM, OSIR
Volume Advances: TRMB, NOAH, STM, FTEK, RAM, OSIR
Trimble Navigation Limited (Public, NASDAQ:TRMB) percentage change (-3.56%), to its trade at $41.85 and its overall traded volume was 1.24M shares during the last session against its average 30 day volume of 508,751.00. The stock has a 52-week range of $52.30-$31.88. At current market price, the market capitalization of the company stands at 5.16B and it has 123.31M outstanding shares.
Trimble Navigation Limited (Trimble) provides advanced positioning product solutions, to commercial and government users. The principal application areas include surveying, agriculture, construction, asset management, mapping and mobile resource management. Trimble’s products include agricultural and construction equipment, guidance systems, surveying instruments, systems that track fleets of vehicles, data collection systems that enable the management of large amounts of geo-referenced information, and information asset management systems for construction and agricultural markets. In addition, the Company also manufactures components for in-vehicle navigation and telematics systems. It operates in four business segments: Engineering and Construction, Field Solutions, Mobile Solutions and Advanced Devices. In May 2011, it acquired Dynamic Survey Solutions, Inc. In May 2011, it acquired MyTopo. In June 2011, the Company acquired Yamei Electronics Technology, Co. Ltd.
Noah Holdings Limited (ADR)(Public, NYSE:NOAH). Last Market Price: $6.15, Change , % Change . Shares trade in the range of $6.06 – $6.43 dollars. It has a market capitalization of 343.64M dollars, making it a Small Cap and has 55.88M outstanding shares. As per the most recent quarterly report, the current earnings per share (EPS) is 0.42. It operates in the Financial sector and belongs to the Misc. Financial Services industry. The company has a 52 week high of $20.00 and a 52 week low of $5.73. The average shares traded over the past 30 days is 124,713.00, while the volume from the current trading session was at 327,375.00 which is 2.63 times the average volume.
Noah Holdings Limited, through its subsidiaries is a service provider focusing on distributing wealth management products to the high net worth population in the People’s Republic of China (PRC). The Company provides direct access to China’s high net worth population. Noah Holdings Limited is a holding company and it operates its business through its PRC subsidiary, Shanghai Noah Rongyao Investment Consulting Co., Ltd (Noah Rongyao), its variable interest entity, Shanghai Noah Investment Management Co., Ltd (Noah Investment), and their respective subsidiaries in China. While Noah Rongyao conducts most of the Company’s businesses, it conducts its insurance brokerage business through Noah Investment and its subsidiaries. Its products choices consist of over-the-counter (OTC) products originated in China and designed to cater to the needs of high net worth population. Its registered clients were 12,353 as of June 30, 2010.
STMicroelectronics N.V. (ADR)(Public, NYSE:STM) percentage change (7.93%), to its trade at $6.40 and its overall traded volume was 3.23M shares during the last session against its average 30 day volume of 1.65M. The stock has a 52-week range of $13.53-$5.34. At current market price, the market capitalization of the company stands at 5.66B and it has 884.98M outstanding shares.
STMicroelectronics N.V. is an independent semiconductor company that designs, develops, manufactures and markets a range of semiconductor products used in a variety of microelectronic applications, including automotive products, computer peripherals, telecommunications systems, consumer products, industrial automation and control systems. Its segments include Automotive, Consumer, Computer and Communication Infrastructure (ACCI); Industrial and Multisegment Sector (IMS), and Wireless. Its products include discretes, microcontrollers, Smartcard products, standard commodity components, micro-electro-mechanical systems (MEMS) and advanced analog products, application-specific standard products (ASICs) and application-specific standard products (ASSPs) for analog, digital, and mixed-signal applications. On May 7, 2010, the Company disposed of its investment in Numonyx Holdings B.V.
Fuel Tech Inc. (Public, NASDAQ:FTEK). Last Market Price: $6.03, Change -0.55, % Change (-8.36%). Shares trade in the range of $5.74 – $6.56 dollars. It has a market capitalization of 143.32M dollars, making it a Micro Cap and has 23.77M outstanding shares. As per the most recent quarterly report, the current earnings per share (EPS) is 0.22. It operates in the Capital Goods sector and belongs to the Misc. Capital Goods industry. The company has a 52 week high of $11.20 and a 52 week low of $3.77. The average shares traded over the past 30 days is 129,244.00, while the volume from the current trading session was at 246,266.00 which is 1.91 times the average volume.
Fuel Tech, Inc. (Fuel Tech) is an integrated company, which uses a range of advanced technologies to provide boiler optimization, improvement and air pollution reduction and control solutions to utility and industrial customers globally. The air pollution control (APC) technology segment reduces NOx emissions in flue gas from boilers, incinerators, furnaces and other stationary combustion sources by utilizing combustion optimization techniques and low NOx and ultra low NOx Burners; NOxOUT and high energy reagent technology (HERT) SNCR systems; systems that incorporate CASCADE, ULTRA and NOxOUT-SCR processes; and ammonia injection grid (AIG) and the graduated straightening grid (GSG) technologies. The FUEL CHEM technology segment improves status of combustion units by controlling slagging, fouling and corrosion.
RAM Energy Resources, Inc. (Public, NASDAQ:RAM) percentage change (-2.24%), to its trade at $3.06 and its overall traded volume was 5.54M shares during the last session against its average 30 day volume of 1.70M. The stock has a 52-week range of $3.45-$0.60. At current market price, the market capitalization of the company stands at 241.16M and it has 78.81M outstanding shares.
RAM Energy Resources, Inc. is an independent oil and natural gas company engaged in the acquisition, development, exploitation, exploration and production of oil and natural gas properties, primarily in Texas, Louisiana and Oklahoma. The wholly owned subsidiaries of the Company include RAM Energy Inc. and RAM Operating Company, Inc. As of December 31, 2010, its estimated net proved reserves were 24.4 million barrels of oil equivalent (MMBoe), of which approximately 54% were crude oil, 36% were natural gas, and 10% were natural gas liquids, or natural gas liquids (NGLs). The Company also owns interests in, and operates, approximately 700 injection wells. As of December 31, 2010, the Company’s proved developed reserves comprised 62% of its total proved reserves. On December 8, 2010, the Company completed the sale to Milagro Producing, LLC. On December 30, 2010, the Company closed the sale of certain non-operated natural gas properties located in eastern Oklahoma.
Osiris Therapeutics, Inc. (Public, NASDAQ:OSIR) percentage change (-4.30%), to its trade at $5.12 and its overall traded volume was 138,728.00 shares during the last session against its average 30 day volume of 68,673.00. The stock has a 52-week range of $8.39-$4.12. At current market price, the market capitalization of the company stands at 168.07M and it has 32.83M outstanding shares.
Osiris Therapeutics, Inc. (Osiris) is a stem cell therapeutic company. It focuses on developing and marketing products to treat serious medical conditions in the inflammatory, autoimmune, orthopedic and cardiovascular areas. The Company’s biologic drug candidate, Prochymal, is being evaluated in Phase III clinical trials for four indications, including acute and steroid refractory graft versus host disease (GvHD), Crohn’s disease and for the repair of gastrointestinal injury resulting from radiation exposure. Prochymal is also being developed for the repair of heart tissue following a heart attack and for protection of pancreatic islet cells in patients with type I diabetes. Its pipeline of internally developed biologic drug candidates under evaluation also includes Chondrogen for osteoarthritis in the knee. The Company is partnered with Genzyme Corporation to develop Prochymal as a medical countermeasure to nuclear terrorism and other radiological emergencies.
